These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6370284)

  • 1. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 2. [The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension].
    Mauro B; Savagnone E
    Boll Soc Ital Cardiol; 1979; 24(2):189-96. PubMed ID: 548094
    [No Abstract]   [Full Text] [Related]  

  • 3. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between the pressure response to spironolactone and or propranolol and the arterial hypertension pattern].
    Chiarini C; Degli Esposti E; Zuccalà A; Bellanova B; Zucchelli P
    Minerva Nefrol; 1974; 21(4):334-9. PubMed ID: 4467054
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K
    Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spironolactone and propranolol in combination therapy of arterial hypertension].
    Di Veroli C; Compagno S; Iugoli AR
    Clin Ter; 1982 Nov; 103(3):283-7. PubMed ID: 7151382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 8. Double blind study with propranolol in the treatment of hypertension.
    De Tollenaere G
    Brux Med; 1973 Nov; Spec No(0):99-110. PubMed ID: 4609568
    [No Abstract]   [Full Text] [Related]  

  • 9. Spiroprop (spironolactone + propranolol) for hypertension.
    Drug Ther Bull; 1985 Apr; 23(8):31-2. PubMed ID: 3996214
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension in patients refractory to therapeutic diuretics. Comparative study of verapamil and propranolol].
    Wajngarten M; Solorzano J; Godoy M; Barretto AC; Pileggi F
    Arq Bras Cardiol; 1982 Jun; 38(6):499-502. PubMed ID: 6762870
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of propranolol in permanent essential hypertension].
    Safar M; Weiss Y; Simon A; Lehner JP; Milliez P
    Ann Med Interne (Paris); 1975 Nov; 126(11):737-43. PubMed ID: 1211699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil and beta-blockers in hypertension: a beneficial drug interaction?
    Dargie HJ
    Br J Clin Pract Suppl; 1985 Jun; 42():44-7. PubMed ID: 3929827
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of arterial hypertension with propranolol (Inderal) in general practice].
    Sederberg-Olsen P; Ronne H; Andersen B
    Ugeskr Laeger; 1976 Nov; 138(47):2953-55. PubMed ID: 790718
    [No Abstract]   [Full Text] [Related]  

  • 15. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA; Boston PF; Chapman J; Pearce MY
    Br J Clin Pract; 1981 Sep; 35(9):317-21. PubMed ID: 7034762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of essential arterial hypertension with a thiazide-spironolactone-reserpine derivative combination].
    Klepping C; Villand J
    J Med Lyon; 1971 Sep; 52(213):1139-41. PubMed ID: 4400152
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative study of spironolactone and chlorthalidone in treatment of hypertension].
    Fagerberg SE; Göransson K
    Lakartidningen; 1974 Jan; 71(3):175-7. PubMed ID: 4837216
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension.
    Jamil MA
    Guys Hosp Rep; 1971; 120(3):207-19. PubMed ID: 4951058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.